Urotensin-II
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Image:U-ii.jpg | |
| Urotensin-II
| |
| Identifiers | |
| Symbol | U-II |
| Entrez | 10911 |
| HUGO | 12636 |
| OMIM | 604097 |
| RefSeq | NM_021995 |
| UniProt | O95399 |
| Other data | |
| Locus | Chr. 1# p36 |
Introduction
Urotensin-II (U-II) is a peptide ligand, initially isolated from the neurosecretory system of the Goby fish (Gillichthys mirabilis) Bern et al. 1969. For many years it was thought that U-II does not exhibit significant effects in mammalian systems; a view quickly overturned when it was demonstrated that Goby U-II produces slow relaxation of mouse annococygeus muscle, in addition to contraction of rat artery segments. In 1998, the cDNA encoding a U-II precursor was cloned in man, unequivocally demonstrating its existence in mammalian species.
U-II Peptide
As with other peptide ligands, U-II is synthesised from a larger precursor molecule, known as Prepro-urotensin-II, two isoforms have been identified in man of lengths 124 and 139 residues. Cleavage of either of these precursors produces identical, eleven residue, mature U-II peptides. The cyclic, C-terminal hexapeptide sequence((-CYS*-TRY-LYS-TRP-PHE-CYS*-), (*bridged CYS residues)), has been conserved through evolution from lamprey to human, species which diverged some 560 million years ago. The fact that such a strong evolutionary pressure has acted to conserve this sequence, highlights its physiological importance, indeed this hexapeptide sequence confers biological activity.
See also
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
